8-K 1 haem-8k.txt BODY OF 8-K SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 26, 2003 HAEMONETICS CORPORATION (Exact Name of Registrant as Specified in its Charter) Massachusetts 1-10730 04-2882273 ------------- ------- ---------- (State or other jurisdiction of (Commission File (IRS Employer incorporation or organization) Number) Identification Number) 400 Wood Road Braintree, MA 02184 ------------- ----- (Address of principal executive (Zip Code) offices) Registrant's telephone number, including area code (781) 848-7100 Item 5. Other Events and Regulation FD Disclosure On March 26, 2003, the Company announced that effective April 1, 2003 Brad Nutter will join the Company as President and CEO following the retirement of James Peterson. Mr. Nutter will replace Mr. Peterson on Haemonetics' Board of Directors. Item 7. Financial Statements and Exhibits. (c) Exhibits. 99.1 Press Release of the Company dated March 26, 2003 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HAEMONETICS CORPORATION Date: March 28, 2003 By: /s/Ronald J. Ryan -------------- -------------------------------- Ronald J. Ryan, Senior Vice President and Chief Financial Officer 3